Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial
Geyer, C.E., Sikov, W.M., Huober, J., Rugo, H.S., Wolmark, N., O’Shaughnessy, J., Maag, D., Untch, M., Golshan, M., Lorenzo, J. Ponce, Metzger, O., Dunbar, M., Symmans, W.F., Rastogi, P., Sohn, J.H., Young, R., Wright, G.S., Harkness, C., McIntyre, K., Yardley, D., Loibl, S.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial
Han, H.S., Arun, B.K., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J.P., Puhalla, S.L., Bach, B.A., Kundu, M.G., Khandelwal, N., Feng, D., Bhattacharya, S., Maag, D., Ratajczak, C.K., Diéras, V.
Published in Annals of oncology (01.03.2022)
Published in Annals of oncology (01.03.2022)
Get full text
Journal Article
Radiologically evident treatment effects in patients with glioblastoma (GBM) and its clinical implications
Gan, H.K., Murone, C., Wong, M., Fitt, G., Kennedy, E., Maag, D., Aldape, K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Positron Emission Tomography Imaging of Poststroke Angiogenesis
WEIBO CAI, GUZMAN, Raphael, LI, Zi-Bo, MAAG, Anne-Lise D, HORI, Nobutaka, HENG ZHAO, MOSELEY, Michael, STEINBERG, Gary K, XIAOYUAN CHEN, HSU, Andrew R, HUI WANG, KAI CHEN, GUOHUA SUN, GERA, Atul, CHOI, Raymond, BLISS, Tonya, LINA HE
Published in Stroke (1970) (2009)
Published in Stroke (1970) (2009)
Get full text
Journal Article
246 PARP inhibitors trap PARP1 onto damaged DNA via catalytic inhibition and not by an allosteric mechanism
Hopkins, T, Solomon, L, Shi, Y, Rodriguez, L, Donawho, C, DiGiammarino, E, Panchal, S, Olson, A, Stolarik, D, Osterling, D, Gao, W, Johnson, E, Maag, D
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
Uncoupling of Initiation Factor eIF5B/IF2 GTPase and Translational Activities by Mutations that Lower Ribosome Affinity
Shin, Byung-Sik, Maag, David, Roll-Mecak, Antonina, Arefin, M.Shamsul, Burley, Stephen K., Lorsch, Jon R., Dever, Thomas E.
Published in Cell (27.12.2002)
Published in Cell (27.12.2002)
Get full text
Journal Article
Template/Primer Requirements and Single Nucleotide Incorporation by Hepatitis C Virus Nonstructural Protein 5B Polymerase
Zhong, W, Ferrari, E, Lesburg, C A, Maag, D, Ghosh, S K, Cameron, C E, Lau, J Y, Hong, Z
Published in Journal of Virology (01.10.2000)
Published in Journal of Virology (01.10.2000)
Get full text
Journal Article
RESULTS FROM A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CRISPR-BASED THERAPY NTLA-2002 FOR HEREDITARY ANGIOEDEMA
Cohn, D., Gurugama, P., Magerl, M., Katelaris, C., Golden, A., Shah, M., Maag, D., Longhurst, H.
Published in Annals of allergy, asthma, & immunology (01.11.2024)
Published in Annals of allergy, asthma, & immunology (01.11.2024)
Get full text
Journal Article
CRISPR/CAS9 EDITING OF KLKB1 IN HEREDITARY ANGIOEDEMA PATIENTS: UPDATED Results: FROM A PHASE 1 STUDY
Cohn, D., Lindsay, K., Gurugama, P., Fijen, L., Petersen, R., Golden, A., Maag, D., Longhurst, H.
Published in Annals of allergy, asthma, & immunology (01.11.2023)
Published in Annals of allergy, asthma, & immunology (01.11.2023)
Get full text
Journal Article
IN VIVO CRISPR/CAS9 EDITING OF KLKB1 IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A FIRST-IN-HUMAN STUDY
Longhurst, H., Fijen, L., Lindsay, K., Butler, J., Golden, A., Maag, D., Xu, Y., Cohn, D.
Published in Annals of allergy, asthma, & immunology (01.11.2022)
Published in Annals of allergy, asthma, & immunology (01.11.2022)
Get full text
Journal Article
MO31-2 Telisotuzumab vedotin monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer
Horinouchi, Hidehito, Goldman, J.W., Moiseenko, F., Cicin, I., Filippova, E., Bar, J., Tomasini, P., Ocampo, C., Sullivan, D., Maag, D., Motwani, M., Jin, J., Camidge, D.R.
Published in Annals of oncology (01.07.2022)
Published in Annals of oncology (01.07.2022)
Get full text
Journal Article
398PRadiologically evident treatment effects in patients with glioblastoma (GBM) and its clinical implications
Gan, H K, Murone, C, Wong, M, Fitt, G, Kennedy, E, Maag, D, Aldape, K
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
325P Characteristics of patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer who achieved durable response in the phase III BROCADE3 study
Kaufman, B., Han, H., Arun, B., Wildiers, H., Friedlander, M., Ayoub, J-P., Puhalla, S., Maag, D., Feng, D., Fages, S., Dieras, V.C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
274O Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study
Dieras, V., Arun, B., Han, H.S., Wildiers, H., Friedlander, M., Ayoub, J.P., Puhalla, S., Hudgens, S., Floden, L., Khandelwal, N., Benjamin, K., Kamalakar, R., Maag, D.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
P60.12 Prevalence of c-Met overexpression (c-Met+) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
Motwani, M., Panchabhai, S., Bar, J., Girard, N., Bradbury, P., Lu, S., Jin, J., Hotson, A., Maag, D., Planchard, D., Camidge, D.R.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
OA15.04 Telisotuzumab Vedotin (teliso-v) Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer
Camidge, D.R., Moiseenko, F., Cicin, I., Horinouchi, H., Filippova, E., Bar, J., Lu, S., Tomasini, P., Ocampo, C., Sullivan, D., Maag, D., Goldman, J.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
P47.03 Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer: Stage 2
Goldman, J., Moiseenko, F., Cicin, I., Horinouchi, H., Filippova, E., Bar, J., Lu, S., Tomasini, P., Ocampo, C., Sullivan, D., Maag, D., Motwani, M., Jin, J., Camidge, D.R.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial
Loibl, S., Sikov, W., Huober, J., Rugo, H.S., Wolmark, N., O'Shaughnessy, J., Maag, D., Untch, M., Golshan, M., Lorenzo, J. Ponce, Metzger, O., Dunbar, M., Symmans, W.F., Geyer, C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article